These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

277 related articles for article (PubMed ID: 38618037)

  • 41. Bacteriophages: the possible solution to treat infections caused by pathogenic bacteria.
    El-Shibiny A; El-Sahhar S
    Can J Microbiol; 2017 Nov; 63(11):865-879. PubMed ID: 28863269
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Eradication of Biofilm-Mediated Methicillin-Resistant Staphylococcus aureus Infections
    Kebriaei R; Lev KL; Shah RM; Stamper KC; Holger DJ; Morrisette T; Kunz Coyne AJ; Lehman SM; Rybak MJ
    Microbiol Spectr; 2022 Apr; 10(2):e0041122. PubMed ID: 35348366
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Targeting antibiotic resistant bacteria with phage reduces bacterial density in an insect host.
    Mikonranta L; Buckling A; Jalasvuori M; Raymond B
    Biol Lett; 2019 Mar; 15(3):20180895. PubMed ID: 30836884
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Bacteriophage therapy against ESKAPE bacterial pathogens: Current status, strategies, challenges, and future scope.
    Kulshrestha M; Tiwari M; Tiwari V
    Microb Pathog; 2024 Jan; 186():106467. PubMed ID: 38036110
    [TBL] [Abstract][Full Text] [Related]  

  • 45. A lytic phage to control multidrug-resistant avian pathogenic
    Yao L; Bao Y; Hu J; Zhang B; Wang Z; Wang X; Guo W; Wang D; Qi J; Tian M; Bao Y; Li H; Wang S
    Front Cell Infect Microbiol; 2023; 13():1253815. PubMed ID: 37743864
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Bacteriophages: a Panacea in Neuro-Urology?
    Leitner L; Kessler TM; Klumpp J
    Eur Urol Focus; 2020 May; 6(3):518-521. PubMed ID: 31732462
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Phage Therapy Is Effective in a Mouse Model of Bacterial Equine Keratitis.
    Furusawa T; Iwano H; Hiyashimizu Y; Matsubara K; Higuchi H; Nagahata H; Niwa H; Katayama Y; Kinoshita Y; Hagiwara K; Iwasaki T; Tanji Y; Yokota H; Tamura Y
    Appl Environ Microbiol; 2016 Sep; 82(17):5332-9. PubMed ID: 27342558
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Isolation and Characterization of Three Pseudomonas aeruginosa Viruses with Therapeutic Potential.
    Wang X; Tang J; Dang W; Xie Z; Zhang F; Hao X; Sun S; Liu X; Luo Y; Li M; Gu Y; Wang Y; Chen Q; Shen X; Xu L
    Microbiol Spectr; 2023 Jun; 11(3):e0463622. PubMed ID: 37125933
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Case Report: Chronic Bacterial Prostatitis Treated With Phage Therapy After Multiple Failed Antibiotic Treatments.
    Johri AV; Johri P; Hoyle N; Pipia L; Nadareishvili L; Nizharadze D
    Front Pharmacol; 2021; 12():692614. PubMed ID: 34177601
    [No Abstract]   [Full Text] [Related]  

  • 50. Can Bacteriophages Replace Antibiotics?
    Skurnik M
    Antibiotics (Basel); 2022 Apr; 11(5):. PubMed ID: 35625219
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Phage-Antibiotic Combination Treatments: Antagonistic Impacts of Antibiotics on the Pharmacodynamics of Phage Therapy?
    Abedon ST
    Antibiotics (Basel); 2019 Oct; 8(4):. PubMed ID: 31614449
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Current review-The rise of bacteriophage as a unique therapeutic platform in treating peri-prosthetic joint infections.
    Akanda ZZ; Taha M; Abdelbary H
    J Orthop Res; 2018 Apr; 36(4):1051-1060. PubMed ID: 28971508
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Phage Resistance Accompanies Reduced Fitness of Uropathogenic Escherichia coli in the Urinary Environment.
    Zulk JJ; Clark JR; Ottinger S; Ballard MB; Mejia ME; Mercado-Evans V; Heckmann ER; Sanchez BC; Trautner BW; Maresso AW; Patras KA
    mSphere; 2022 Aug; 7(4):e0034522. PubMed ID: 35920561
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Limitations of Phage Therapy and Corresponding Optimization Strategies: A Review.
    Lin J; Du F; Long M; Li P
    Molecules; 2022 Mar; 27(6):. PubMed ID: 35335222
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Framing the Future with Bacteriophages in Agriculture.
    Svircev A; Roach D; Castle A
    Viruses; 2018 Apr; 10(5):. PubMed ID: 29693561
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Community-acquired pneumonia: aetiology, antibiotic resistance and prospects of phage therapy.
    Sheam MM; Syed SB; Nain Z; Tang SS; Paul DK; Ahmed KR; Biswas SK
    J Chemother; 2020 Dec; 32(8):395-410. PubMed ID: 32820711
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Bacteriophage-based approach for treatment of urinary tract infections: a quick outlook.
    Grygorcewicz B; Gliźniewicz M; Jabłońska J; Augustyniak A; Olszewska P; Wojciuk B; Miłek D; Serwin N; Czajkowski A; Cecerska-Heryć E; Rakoczy R; Cymbaluk-Płoska A
    APMIS; 2024 Feb; 132(2):81-93. PubMed ID: 38031200
    [TBL] [Abstract][Full Text] [Related]  

  • 58. A historical overview of bacteriophage therapy as an alternative to antibiotics for the treatment of bacterial pathogens.
    Wittebole X; De Roock S; Opal SM
    Virulence; 2014 Jan; 5(1):226-35. PubMed ID: 23973944
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Optimization of Phage-Antibiotic Combinations against Staphylococcus aureus Biofilms.
    Kebriaei R; Lehman SM; Shah RM; Stamper KC; Kunz Coyne AJ; Holger D; El Ghali A; Rybak MJ
    Microbiol Spectr; 2023 Jun; 11(3):e0491822. PubMed ID: 37199616
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Bacteriophage as an antibacterial agent: a patent perspective.
    Pathak-Vaidya P; Sharma S; Telang M
    Future Microbiol; 2021 Nov; 16():1327-1339. PubMed ID: 34755539
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.